ALXO (ALXO:NASDAQ) shot up at $112.26, representing a gain of 37.4%. On Wed 09 Dec 20, ALXO:NASDAQ hit a New 2-Week High of $81.73. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 05:09 AM in the 'PUBLIC OFFERING' category. From Wed 25 Nov 20, the stock recorded 66.67% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About ALXO (ALXO:NASDAQ)
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company. The firm is focused on developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Top 10 Gainers:
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 176.37%
- Immutep Limited (IMMP:NASDAQ), 164.65%
- Veru Inc. (VERU:NASDAQ), 53.47%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 52.98%
- Neos Therapeutics, Inc. (NEOS:NASDAQ), 47.7%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 40.85%
- Arlington Asset Investment Corp. (AI:NYSE), 40.56%
- Peabody Energy Corporation (BTU:NYSE), 37.84%
- ALXO (ALXO:NASDAQ), 37.35%
- Silver Spike Acquisition Corp. (SSPK:NASDAQ), 37.27%